Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

Novo Nordisk (NVO) ended a five-day losing streak on Thursday after Kepler Cheuvreux, a long-time skeptic of the Danish biotech, finally issued a bullish rating on the maker of hugely popular obesity/ ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy ... The company said a Phase 3 trial showed that after 68 weeks, those who took CagriSema achieved ...